Empagliflozin is a sodium-glucose co-transporter-2 (SGLT2) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes. To support rigorous… Read more


















































Empagliflozin is a sodium-glucose co-transporter-2 (SGLT2) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes. To support rigorous pharmaceutical analysis, this category provides a comprehensive selection of reference standards, including the active pharmaceutical ingredient, critical process-related impurities, potential degradation products, and metabolites. These compounds are essential for laboratories conducting impurity profiling, method validation, and stability testing. Researchers utilize these high-quality standards—including stable isotope-labelled compounds—for precise identification and quantification in complex matrices using analytical techniques such as HPLC, LC-MS, and NMR. By providing these materials, the catalogue facilitates compliance with regulatory expectations for quality control and the toxicological evaluation of drug-related impurities during the lifecycle of the pharmaceutical product.